SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today is hosting its 2019
Investor Day in New York City with
presentations by Chief Executive Officer J.
Christopher Barry and other members of the management
team.
"At NuVasive's 2019 Investor Day, I look forward to sharing the
Company's go-forward strategy to build on our foundation as the
innovation leader in spine with a roadmap to deliver sustained,
above-market growth," said J. Christopher Barry, chief executive officer
of NuVasive.
Management will discuss NuVasive's strategic framework related
to:
- Company priorities: Transform outcomes through
best-in-class technology; continue to be the trusted partner for
patients and customers by optimizing surgical solutions and
providing industry-leading surgeon education and training; and
deliver on commitments to patients, surgeons, employees and
shareholders.
- Technology strategies: Build upon existing leadership
position in the lateral spine surgery market segment to drive
increased adoption of less invasive surgery with innovative and
enabling technologies; and continue to grow in open spine surgery
market segments where the Company is under represented, including
cervical and deformity.
- Market expansion: Drive deliberate geographical
expansion and deployment of market relevant technologies to improve
patient care, increase market share and nearly double International
revenue by 2024, while making strategic investments necessary to
scale business systems and infrastructure.
- Five-year financial outlook: Execute on long-term
financial model that supports mid-single digit growth, increased
operating leverage and generates strong cash flow with a balanced
capital deployment plan.
Webcast Information
NuVasive will host a live
webcast of its 2019 Investor Day today, August 8, 2019 at 8:30
a.m. EDT/5:30 a.m. PDT. The
webcast and presentation materials will address the Company's
strategic framework, including the Company's five-year financial
performance goals for revenue, investment in research and
development, profitability and free cash generation. The webcast
can be accessed from the Investor Relations page of the Company's
website at www.nuvasive.com. A replay of the event and the
presentation materials will be available on the same website
following the conclusion of the meeting.
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
more than $1 billion in revenues,
NuVasive has approximately 2,600 employees and operates in more
than 50 countries serving surgeons, hospitals and patients. For
more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release and the webcast
of 2019 Investor Day that are not a description of historical facts
are forward-looking statements that involve risks, uncertainties,
assumptions and other factors which, if they do not materialize or
prove correct, could cause NuVasive's results to differ materially
from historical results or those expressed or implied by such
forward-looking statements. Forward-looking statements include, but
are not limited to, statements regarding NuVasive's financial
guidance for 2019, and longer-term financial and business goals.
The potential risks and uncertainties which contribute to the
uncertain nature of these statements include, among
others, the risk that NuVasive's revenue or earnings
projections may turn out to be inaccurate because of the
preliminary nature of the forecasts; the risk of further adjustment
to financial results or future financial and business expectations;
unanticipated difficulty in selling products, generating revenue or
producing expected profitability; risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products (including the iGA®
platform), the Company's ability to effectually manage inventory as
it continues to release new products, its ability to recruit and
retain management and key personnel, and the other risks and
uncertainties described in NuVasive's news releases and periodic
filings with the Securities and Exchange Commission. NuVasive's
public filings with the Securities and Exchange Commission are
available at www.sec.gov. NuVasive assumes no obligation to update
any forward-looking statement to reflect events or circumstances
arising after the date on which it was made.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nuvasive-presents-long-term-strategy-and-financial-outlook-at-2019-investor-day-300898151.html
SOURCE NuVasive, Inc.